Page last updated: 2024-09-03

gefitinib and Lymphangitis

gefitinib has been researched along with Lymphangitis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chua, KT; Lai, NL; Lee, CH; Liam, CK; Lim, BK; Pang, YK	1
Asada, K; Chida, K; Hasegawa, H; Naito, T; Suda, T	1

Other Studies

2 other study(ies) available for gefitinib and Lymphangitis

Article	Year
Successful pregnancy with epidermal growth factor receptor tyrosine kinase inhibitor treatment of metastatic lung adenocarcinoma presenting with respiratory failure. Lung cancer (Amsterdam, Netherlands), 2011, Volume: 74, Issue:2 Topics: Adenocarcinoma; Adult; Disease Progression; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Lung Neoplasms; Lymphangitis; Lymphatic Metastasis; Neoplasm Staging; Pleural Effusion, Malignant; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Third; Quinazolines; Remission Induction; Respiratory Insufficiency; Sequence Deletion; Term Birth	2011
Lymphangitis carcinomatosis as a potential predictor for a response to gefitinib. Clinical oncology (Royal College of Radiologists (Great Britain)), 2006, Volume: 18, Issue:7 Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma; Female; Forecasting; Gefitinib; Humans; Lung Neoplasms; Lymphangitis; Male; Quinazolines; Treatment Outcome	2006

Article

Year

Successful pregnancy with epidermal growth factor receptor tyrosine kinase inhibitor treatment of metastatic lung adenocarcinoma presenting with respiratory failure.

Lung cancer (Amsterdam, Netherlands), 2011, Volume: 74, Issue:2

Topics: Adenocarcinoma; Adult; Disease Progression; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Lung Neoplasms; Lymphangitis; Lymphatic Metastasis; Neoplasm Staging; Pleural Effusion, Malignant; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, Third; Quinazolines; Remission Induction; Respiratory Insufficiency; Sequence Deletion; Term Birth

2011

Lymphangitis carcinomatosis as a potential predictor for a response to gefitinib.

Clinical oncology (Royal College of Radiologists (Great Britain)), 2006, Volume: 18, Issue:7

Topics: Adenocarcinoma; Antineoplastic Agents; Carcinoma; Female; Forecasting; Gefitinib; Humans; Lung Neoplasms; Lymphangitis; Male; Quinazolines; Treatment Outcome

2006